Identification of HLA-Cw6.02 and HLA-Cw7.01 allele-specific binding motifs by screening synthetic peptide libraries

Immunogenetics

Volumn 56, Issue 6, 2004, Pages 391-398

  Dionne, Sara O ^a   Lake, Douglas F ^a   Grimes, William J ^a   Smith, Margaret H ^a  

^a UNIVERSITY OF ARIZONA   (United States)

Author keywords

Combinatorial peptide library; HLA Cw6; HLA Cw7; Peptide motif

Indexed keywords

ALKALINE PHOSPHATASE; BETA 2 MICROGLOBULIN; EPITOPE; HLA A ANTIGEN; HLA ANTIBODY; HLA B ANTIGEN; HLA C ANTIGEN; HLA CW6 ANTIGEN; HLA CW7 ANTIGEN; PEPTIDE LIBRARY; TUMOR ANTIGEN; UNCLASSIFIED DRUG;

AMINO ACID SEQUENCE; ANTIBODY COMBINING SITE; ARTICLE; BACULOVIRUS EXPRESSION SYSTEM; COMBINATORIAL LIBRARY; CONTROLLED STUDY; CYTOTOXIC T LYMPHOCYTE; GENE AMPLIFICATION; HUMAN; HUMAN CELL; IMMUNOTHERAPY; MAJOR HISTOCOMPATIBILITY COMPLEX; NATURAL KILLER CELL; PRIORITY JOURNAL; PROTEIN MOTIF;

ALKALINE PHOSPHATASE; ALLELES; BETA 2-MICROGLOBULIN; BINDING SITES; CELLS, CULTURED; COMBINATORIAL CHEMISTRY TECHNIQUES; EPITOPES; HLA-C ANTIGENS; HUMANS; IMMUNOCONJUGATES; LYMPHOCYTES; PEPTIDE FRAGMENTS; PEPTIDE LIBRARY; PROTEIN BINDING; RECOMBINANT PROTEINS;

UNIDENTIFIED BACULOVIRUS;

EID: 5344248600     PISSN: 00937711     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00251-004-0710-1     Document Type: Article

References (37)

1. Baba E, Erskine R, Boyson JE, Cohen GB, Davis DM, Malik P, Mandelboim O, Reyburn HT, Strominger JL (2000) N-linked carbohydrate on human leukocyte antigen-C and recognition by natural killer cell inhibitory receptors. Hum Immunol 61:1202
2. Bettinotti MP, Panelli MC, Ruppe E, Mocellin S, Phan GQ, White DE, Marincola FM (2003) Clinical and immunological evaluation of patients with metastatic melanoma undergoing immunization with the HLA-Cw*0702- associated epitope MAGE-A12:170-178. Int J Cancer 105:210
3. Bruggen P van der, Szikora JP, Boel P, Wildmann C, Somville M, Sensi M, Boon T (1994) Autologous cytolytic T lymphocytes recognize a MAGE-1 nonapeptide on melanomas expressing HLA-Cw*1601. Eur J Immunol 24:2134
4. Carlin LM, Eleme K, McCann FE, Davis DM (2001) Intercellular transfer and supramolecular organization of human leukocyte antigen C at inhibitory natural killer cell immune synapses. J Exp Med 194:1507
5. Castelli C, Tarsini P, Mazzocchi A, Rini F, Rivoltini L, Ravagnani F, Gallino F, Belli F, Parmiani G (1999) Novel HLA-Cw8-restricted T cell epitopes derived from tyrosinase-related protein-2 and gp100 melanoma antigens. J Immunol 162:1739
6. Chen JL, Dunbar PR, Gileadi U, Jager E, Gnjatic S, Nagata Y, Stockert E, Panicali DL, Chen YT, Knuth A, Old LJ, Cerundolo V (2000) Identification of NY-ESO-1 peptide analogues capable of improved stimulation of tumor-reactive CTL. J Immunol 165:948
7. Chiari R, Foury F, De Plaen E, Baurain JF, Thonnard J, Coulie PG (1999) Two antigens recognized by autologous cytolytic T lymphocytes on a melanoma result from a single point mutation in an essential housekeeping gene. Cancer Res 59:5785
8. Davis DM, Mandelboim O, Luque I, Baba E, Boyson J, Strominger JL (1999) The transmembrane sequence of human histocompatibility leukocyte antigen (HLA)-C as a determinant in inhibition of a subset of natural killer cells. J Exp Med 189:1265
9. Dionne SO, Smith MH, Marincola FM, Lake DF (2001) Antigen presentation of a modified tumor-derived peptide by tumor infiltrating lymphocytes. Cell Immunol 214:139
10. Dionne SO, Smith MH, Marincola FM, Lake DF (2003) Functional characterization of CTL against gp100 altered peptide ligands. Cancer Immunol Immunother 52:199
11. Dionne SO, Myers CE, Smith MH, Lake DF (2004) Her-2/neu altered peptide ligand-induced CTL responses: implications for peptides with increased HLA affinity and T-cell-receptor interaction. Cancer Immunol Immunother 53:307-314
12. Ennis PD, Zemmour J, Salter RD, Parham P (1990) Rapid cloning of HLA-A, B cDNA by using the polymerase chain reaction: frequency and nature of errors produced in amplification. Proc Natl Acad Sci USA 87:2833
13. Falk CS, Schendel DJ (1997) HLA-C revisited. Ten years of change. Immunol Res 16:203
14. Falk K, Rotzschke O, Stevanovic S, Jung G, Rammensee HG (1991) Allele-specific motifs revealed by sequencing of self-peptides eluted from MHC molecules. Nature 351:290
15. Falk K, Rotzschke O, Grahovac B, Schendel D, Stevanovic S, Gnau V, Jung G, Strominger JL, Rammensee HG (1993) Allele-specific peptide ligand motifs of HLA-C molecules. Proc Natl Acad Sci USA 90:12005
16. Fan QR, Long EO, Wiley DC (2001) Crystal structure of the human natural killer cell inhibitory receptor KIR2DL1-HLA-Cw4 complex. Nat Immunol 2:452
17. Farina C, van der Bruggen P, Boel P, Parmiani G, Sensi M (1996) Conserved TCR usage by HLA-Cw* 1601-restricted T cell clones recognizing melanoma antigens. Int Immunol 8:1463
18. Garboczi DN, Hung DT, Wiley DC (1992) HLA-A2-peptide complexes: refolding and crystallization of molecules expressed in Escherichia coli and complexed with single antigenic peptides. Proc Natl Acad Sci USA 89:3429
19. Gnjatic S, Nagata Y, Jager E, Stockert E, Shankara S, Roberts BL, Mazzara GP, Lee SY, Dunbar PR, Dupont B, Cerundolo V, Ritter G, Chen YT, Knuth A, Old LJ (2000) Strategy for monitoring T cell responses to NY-ESO-1 in patients with any HLA class I allele. Proc Natl Acad Sci USA 97:10917
20. Groop L, Koskimies S, Pelkonen R, Tolppanen EM (1983) Increased frequency of HLA-Cw4 in type 2 diabetes. Acta Endocrinol (Copenh) 104:475
21. Heidecker L, Brasseur F, Probst-Kepper M, Gueguen M, Boon T, Van den Eynde BJ (2000) Cytolytic T lymphocytes raised against a human bladder carcinoma recognize an antigen encoded by gene MAGE-A12. J Immunol 164:6041
22. Hoffmann TK, Loftus DJ, Nakano K, Maeurer MJ, Chikamatsu K, Appella E, Whiteside TL, DeLeo AB (2002) The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264-272) epitope. J Immunol 168:1338
23. Hunt DF, Henderson RA, Shabanowitz J, Sakaguchi K, Michel H, Sevilir N, Cox AL, Appella E, Engelhard VH (1992) Characterization of peptides bound to the class I MHC molecule HLA-A2.1 by mass spectrometry. Science 255:1261
24. Lam KS, Salmon SE, Hersh EM, Hruby VJ, Kazmierski WM, Knapp RJ (1991) A new type of synthetic peptide library for identifying ligand-binding activity. Nature 354:82
25. Lam KS, Lebl M, Krchnak V (1997) The "one-bead-one-compound" combinatorial library method. Chem Rev 97:411
26. Madden DR (1995) The three-dimensional structure of peptide-MHC complexes. Annu Rev Immunol 13:587
27. Panelli MC, Bettinotti MP, Lally K, Ohnmacht GA, Li Y, Robbins P, Riker A, Rosenberg SA, Marincola FM (2000) A tumor-infiltrating lymphocyte from a melanoma metastasis with decreased expression of melanoma differentiation antigens recognizes MAGE-12. J Immunol 164:4382
28. Rammensee H-G, Bachnann J, Stevanovic S (1997) MHC ligands and peptide motifs. Landes Bioscience/Chapman and Hall, Austin
29. Richardson J, Reyburn HT, Luque I, Vales-Gomez M, Strominger JL (2000) Definition of polymorphic residues on killer Ig-like receptor proteins which contribute to the HLA-C binding site. Eur J Immunol 30:1480
30. Rosenberg SA, Yang JC, Schwartzentruber DJ, Hwu P, Marincola FM, Topalian SL, Restifo NP, Dudley ME, Schwarz SL, Spiess PJ, Wunderlich JR, Parkhurst MR, Kawakami Y, Seipp CA, Einhorn JH, White DE (1998) Immunologic and therapeutic evaluation of a synthetic peptide vaccine for the treatment of patients with metastatic melanoma. Nat Med 4:321
31. Saper MA, Bjorkman PJ, Wiley DC (1991) Refined structure of the human histocompatibility antigen HLA-A2 at 2.6 A resolution. J Mol Biol 219:277
32. Sawicki MW, Dimasi N, Natarajan K, Wang J, Margulies DH, Mariuzza RA (2001) Structural basis of MHC class I recognition by natural killer cell receptors. Immunol Rev 181:52
33. Smith MH, Lam KS, Hersh EM, Lebl M, Grimes WJ (1994) Peptide sequences binding to MHC class I proteins. Mol Immunol 31:1431
34. Smith MH, Nuara AA, Egen JG, Sirjani DB, Lam KS, Grimes WJ (1998) Baculoviral expressed HLA class I heavy chains used to screen a synthetic peptide library for allele-specific peptide binding motifs. Mol Immunol 35:1033
35. Townsend A, Bodmer H (1989) Antigen recognition by class I-restricted T lymphocytes. Annu Rev Immunol 7:601
36. Van den Eynde B, Peelers O, De Backer O, Gaugler B, Lucas S, Boon T (1995) A new family of genes coding for an antigen recognized by autologous cytolytic T lymphocytes on a human melanoma. J Exp Med 182:689
37. Zemmour J, Parham P (1992) Distinctive polymorphism at the HLA-C locus: implications for the expression of HLA-C. J Exp Med 176:937